MEKINIST vs RAPAMUNE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. MEKINIST and RAPAMUNE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MEKINIST	RAPAMUNE
Rating	70/100	New
Pharmacy pays	—	~$48.61 /30
Type	RX	RX
Active ingredient	TRAMETINIB DIMETHYL SULFOXIDE	SIROLIMUS
Manufacturer	Novartis	Pf Prism Cv
Dosage forms	Powder, Tablet	Solution
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Non-Small-Cell Lung Carcinoma, Melanoma	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

mekinist rapamune

Rating

70/100

New

Pharmacy pays

—

~$48.61 /30

Type

Active ingredient

TRAMETINIB DIMETHYL SULFOXIDE

SIROLIMUS

Manufacturer

Novartis

Pf Prism Cv

Dosage forms

Powder, Tablet

Solution

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Non-Small-Cell Lung Carcinoma, Melanoma

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

What is the difference between Mekinist and Rapamune?

Mekinist contains Trametinib Dimethyl Sulfoxide, while Rapamune contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.